Amneal Pharmaceuticals (AMRX) Market Capitalization (2018 - 2026)

Amneal Pharmaceuticals has reported Market Capitalization for 9 years, with the latest figure at $5.5 billion in Q2 2026.

• On a quarterly basis, Market Capitalization rose 117.56% year-over-year to $5.5 billion in Q2 2026; TTM through Jun 2026 was $5.5 billion, a 117.56% increase from a year earlier, with the FY2025 full-year figure at $4.0 billion, up 61.48% from the prior year.
• Market Capitalization was $5.5 billion for Q2 2026 at Amneal Pharmaceuticals, up from $4.0 billion in the prior quarter.
• The five-year high for Market Capitalization was $5.5 billion in Q2 2026, with the low at $424.6 million in Q1 2023.
• Average Market Capitalization over 5 years is $2.1 billion, with a median of $1.9 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Market Capitalization plunged 66.38% in 2023, then jumped 340.53% in 2024.
• Over 5 years, Market Capitalization stood at $604.2 million in 2022, then jumped by 207.89% to $1.9 billion in 2023, then jumped by 31.97% to $2.5 billion in 2024, then jumped by 61.48% to $4.0 billion in 2025, then jumped by 39.44% to $5.5 billion in 2026.
• The last three Market Capitalization figures came in at $5.5 billion (Q2 2026), $4.0 billion (Q1 2026), and $4.0 billion (Q4 2025), per Business Quant data.